The Future of The Diabetes Care Devices Market to 2016

The Key Demand Drivers Remain Intact

Product Code GBI00021
Publication Date January 2010
Publisher GBI Research
Product Type Report
Pages 92
ISBN Number not applicable
Change currency
PDF £2,215.00 €2,667 $3,502 BUY >
Order by fax
Ask a question about this product > Receive product alerts > Call now +44 20 7060 7474

The Future of The Diabetes Care Devices Market to 2016

The Key Demand Drivers Remain Intact

GBI Research's new report, 'The Future of the Diabetes Care Devices Market to 2016 - The Key Demand Drivers Remain Intact' provides key data, information and analysis on the global diabetes care devices market, a key segment within the medical equipment industry. This medical device report provides market landscape, competitive landscape and market trends information on two diabetes care devices market categories - glucose monitoring and insulin delivery. The report provides comprehensive information on the key trends affecting these categories, and key analytical content on the market dynamics. The report also reviews the competitive landscape, key pipeline products and technology offerings. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GBI Research's team of industry experts.

Scope

  • Key geographies including the US (United States), Canada, the UK (United Kingdom), Germany, France, Italy, Spain, Japan, China, India, Australia and Brazil.
  • Global Market size and company share data for three diabetes care devices market categories - glucose monitoring and insulin delivery.
  • Annualized market revenues data from 2002 to 2009, forecast forward for 7 years to 2016. Company shares data for 2008.
  • Qualitative analysis of key market trends, market drivers and restraints by categories and segments.
  • Competitive landscape and key company profiles. Key players covered include Roche, LifeScan, Bayer, Abbott, Becton, Dickinson, Medtronic, Novo Nordisk, Sanofi-Aventis, Eli Lilly, ARKRAY, Terumo, Animas and Smiths Medical.
  • Key in-pipeline products and technologies expected to hit the global diabetes care devices market in the near future.

Reasons to buy

  • Develop business strategies by understanding the trends and developments that are driving the diabetes care devices market globally.
  • Design and develop your product development, marketing and sales strategies.
  • Exploit M&A opportunities by identifying market players with the most innovative pipeline.
  • Develop market-entry and market expansion strategies.
  • Identify key players best positioned to take advantage of the emerging market opportunities.
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return.
  • What's the next big thing in the diabetes care devices market landscape? - Identify, understand and capitalize.
  • Make more informed business decisions from the insightful and in-depth analysis of the diabetes care devices market and the factors shaping it.

Contents

  • 1. Table of Contents
    • 1.1 List of Tables
    • 1.2 List of Figures
  • 2 Diabetes: Disease Overview
    • 2.1 Type 1 Diabetes
    • 2.2 Type 2 Diabetes
    • 2.3 Impaired Glucose Tolerance
    • 2.4 Diabetes Accentuating Cardiovascular Disease
      • 2.4.1 Atherosclerosis
      • 2.4.2 Diabetic Cardiomyopathy (DCM)
      • 2.4.3 Stroke
      • 2.4.4 Renal Disease
    • 2.5 Diabetes a Burden on Healthcare Spending
  • 3 Diabetes Care Devices Market: Market Characterization
    • 3.1 Global Diabetes Care Devices Market, Revenue ($m), 2002 - 2009
    • 3.2 Global Diabetes Care Devices Market, Revenue Forecasts ($m), 2009 - 2016
    • 3.3 Diabetes Care Devices, Key Market Trends
      • 3.3.1 Home Healthcare Driving Growth in the Diabetes Care Devices Market
      • 3.3.2 Brand Loyalty in Diabetes Care Devices Depends on Innovation and Price
      • 3.3.3 Low Reimbursement for New Diabetes Care Technologies Restraining the Market
      • 3.3.4 Drug Stores to Remain the Major Distribution Channels for Diabetes Care Devices
    • 3.4 Diabetes Care Devices: Technological Trends
      • 3.4.1 Innovation in Diabetes Care Devices Aimed at Enhancing Life of Diabetics
      • 3.4.2 Continuous Glucose Monitoring (CGM) to Position Itself as a Major Diabetes Monitoring Technology
      • 3.4.3 Disposable Insulin Pumps to Gain Share over Traditional Insulin Pumps
      • 3.4.4 Pain Free Glucose Monitoring Devices Will Drive Future Growth in the Diabetes Care Device Market
      • 3.4.5 The Demand for Pain Free Insulin Delivery Devices is Increasing
      • 3.4.6 Remote Glucose Monitoring to Bolster Compliance Rate in Diabetics
    • 3.5 Diabetes Care Devices Market Drivers
      • 3.5.1 New Technologies to Boost Sales in the Future
      • 3.5.2 Increasing Prevalence of Diabetes to Boost Sales
      • 3.5.3 The Increasing Aging Population of the World to Increase Patient Population
      • 3.5.4 Increasing Awareness of Better Diabetes Management
      • 3.5.5 Lifestyle Changes Bringing About the Increase in Disease Prevalence
    • 3.6 Diabetes Care Devices Market Restraints
      • 3.6.1 Lack of Affordability and Awareness in Developing Nations
      • 3.6.2 Lack of Reimbursement for New Technologies
      • 3.6.3 Low Diagnosis Rate
      • 3.6.4 Low Patient Compliance
      • 3.6.5 High Cost Is a Restraint for Insulin Pens and Pumps
      • 3.6.6 Device Recalls Negatively Affect Physician and Patient Perceptions
      • 3.6.7 Low Prescription Rates and Limited Storage Facilities in the Developing World Restraining the Diabetes Care Devices Market
    • 3.7 Global Diabetes Care Devices Market, Company Share (%), 2008
  • 4 Global Diabetes Care Devices Market: Cross-Segment Market Analysis and Forecasts
    • 4.1 Glucose Monitoring Market
      • 4.1.1 Global Glucose Monitoring Market, Revenue ($m), 2002 - 2009
      • 4.1.2 Global Glucose Monitoring Market, Revenue Forecasts ($m), 2009 - 2016
      • 4.1.3 Glucose Monitoring Market Drivers
      • 4.1.4 Glucose Monitoring Market Restraints
      • 4.1.5 Glucose Monitoring Market by Segment
    • 4.2 Insulin Delivery Devices
      • 4.2.1 Global Insulin Delivery, Revenue ($m), Global, 2002 - 2009
      • 4.2.2 Global Insulin Delivery, Revenue ($m), Global, 2009 - 2016
      • 4.2.3 Insulin Delivery Devices Market Drivers
      • 4.2.4 Insulin Delivery Devices Market Restraints
      • 4.2.5 Insulin Delivery Devices Market by Segment
  • 5 Diabetes Care Devices: Competitive Landscape
    • 5.1 Insulin Delivery Devices Market
      • 5.1.1 Strategic Product Assessment
      • 5.1.2 Insulin Delivery Devices, Company Share (%), 2008
    • 5.2 Glucose Monitoring Systems
      • 5.2.1 Overview
      • 5.2.2 Strategic Product Assessment
      • 5.2.3 Glucose Monitoring Systems Company Share (%)
    • 5.3 Key Company Profiles
      • 5.3.1 F. Hoffmann-La Roche Ltd
      • 5.3.2 LifeScan (Johnson & Johnson)
      • 5.3.3 Bayer Healthcare
      • 5.3.4 Abbott Laboratories
      • 5.3.5 Becton, Dickinson and Company
      • 5.3.6 Medtronic
      • 5.3.7 Novo Nordisk
      • 5.3.8 Others
      • 5.3.9 Product Profiles of the Major Marketed Products in the Glucose Monitoring Systems Market
      • 5.3.10 OneTouch UltraMini
      • 5.3.11 Contour Meter
  • 6 Global Diabetes Care Devices Market: Cross-Country Analysis and Forecasts
    • 6.1 Revenue, By Country, 2002 - 2009
      • 6.1.1 The US Diabetes Care Devices Market, Revenue ($m), 2002 - 2009
      • 6.1.2 Canada Diabetes Care Devices Market, Revenue ($m), 2002 - 2009
      • 6.1.3 The UK Diabetes Care Devices Market, Revenue ($m), 2002 - 2009
      • 6.1.4 Germany Diabetes Care Devices Market, Revenue ($m), 2002 - 2009
      • 6.1.5 France Diabetes Care Devices Market, Revenue ($m), 2002 - 2009
      • 6.1.6 Italy Diabetes Care Devices Market, Revenue ($m), 2002 - 2009
      • 6.1.7 Spain Diabetes Care Devices Market, Revenue ($m), 2002 - 2009
      • 6.1.8 Japan Diabetes Care Devices Market, Revenue ($m), 2002 - 2009
      • 6.1.9 China Diabetes Care Devices Market, Revenue ($m), 2002 - 2009
      • 6.1.10 India Diabetes Care Devices Market, Revenue ($m), 2002 - 2009
      • 6.1.11 Australia Diabetes Care Devices Market, Revenue ($m), 2002 - 2009
      • 6.1.12 Brazil Diabetes Care Devices Market, Revenue ($m), 2002 - 2009
    • 6.2 Revenue Forecasts, By Country, 2009 - 2016
      • 6.2.1 The US Diabetes Care Devices Market, Revenue ($m), 2009 - 2016
      • 6.2.2 Canada Diabetes Care Devices Market, Revenue ($m), 2009 - 2016
      • 6.2.3 The UK Diabetes Care Devices Market, Revenue ($m), 2009 - 2016
      • 6.2.4 Germany Diabetes Care Devices Market, Revenue ($m), 2009 - 2016
      • 6.2.5 France Diabetes Care Devices Market, Revenue ($m), 2009 - 2016
      • 6.2.6 Italy Diabetes Care Devices Market, Revenue ($m), 2009 - 2016
      • 6.2.7 Spain Diabetes Care Devices Market, Revenue ($m), 2009 - 2016
      • 6.2.8 Japan Diabetes Care Devices Market, Revenue ($m), 2009 - 2016
      • 6.2.9 China Diabetes Care Devices Market, Revenue ($m), 2009 - 2016
      • 6.2.10 India Diabetes Care Devices Market, Revenue ($m), 2009 - 2016
      • 6.2.11 Australia Diabetes Care Devices Market, Revenue ($m), 2009 - 2016
      • 6.2.12 Brazil Diabetes Care Devices Market, Revenue ($m), 2009 - 2016
  • 7 Diabetes Care Devices: Pipeline Analysis
    • 7.1 Glucose Monitoring Key Pipeline Products
      • 7.1.1 Strategic Pipeline Assessment
      • 7.1.2 Profiles of Promising Devices under Clinical Development
      • 7.1.3 Glucose Monitoring Systems Pipeline Product Summary by Product Type
      • 7.1.4 Glucose Monitoring Systems Pipeline Product Summary: Home Glucose Monitoring Systems
      • 7.1.5 Glucose Monitoring Systems Pipeline Product Summary: Hospital Setting Glucose Monitoring Systems
      • 7.1.6 Glucose Monitoring Systems Pipeline Product Summary: Both Home and Hospital Setting Glucose Monitoring Systems
    • 7.2 Future Market Competition in Glucose Monitoring Devices
    • 7.3 Global Glucose Monitoring Systems Market: Emerging Companies
      • 7.3.1 Introduction
    • 7.4 Insulin Delivery Key Pipeline Products
      • 7.4.1 Overview
      • 7.4.2 Strategic Pipeline Assessment
      • 7.4.3 Insulin Delivery Devices - Clinical Pipeline by Mode of Insulin Delivery
    • 7.5 Global Insulin Delivery Devices Pipeline Product Summary
    • 7.6 Insulin Delivery Devices - Promising Devices under Clinical Development
      • 7.6.1 Closed-loop diabetes management system
      • 7.6.2 Paradigm Veo System
      • 7.6.3 Future Market Competition in Insulin Delivery Devices
  • 8 Global Diabetes Care Devices Market: Consolidation Landscape
    • 8.1 Deals by Type 2006 - 2009
    • 8.2 Key Mergers and Acquisitions, Diabetes Care Devices, 2006 - 2009
      • 8.2.1 Bayer HealthCare Completes Acquisition Of iSense
      • 8.2.2 Ypsomed Holding Acquires 10% Equity Stake In BIONIME
      • 8.2.3 Mediscience Technology Acquires SensiVida Medical Systems
      • 8.2.4 Medco Health Solutions Acquires PolyMedica
      • 8.2.5 Bayer HealthCare Diabetes Care Acquires Metrika
  • 9 Appendix
    • 9.1 Methodology
      • 9.1.1 Secondary Research
      • 9.1.2 Primary Research
      • 9.1.3 Models
      • 9.1.4 Forecasts
      • 9.1.5 Expert Panels
    • 9.2 Contact Us
    • 9.3 Disclaimer
    • Table 1: Prevalence of Impaired Glucose Tolerance, 2030, Global
    • Table 2: Diabetes Care Devices, Revenue ($m), Global, 2002 - 2009
    • Table 3: Diabetes Care Devices, Revenue ($m), Global, 2009 - 2016
    • Table 4: Average Cost of Therapy, Traditional Glucose Meter Vs Continuous Glucose Monitor, 2009
    • Table 5: Disposable Insulin Pumps, Revenue ($m), US, 2005 - 2009
    • Table 6: Disposable Insulin Pumps, Revenue ($m), US, 2009 - 2016
    • Table 7: Non Invasive Glucose Monitoring Products
    • Table 8: Oral Insulin Delivery Products under Development, 2009
    • Table 9: Diabetes Mellitus, Estimated Patient Population (‘000’s), 2030
    • Table 10: Population Over the age of 65 (‘000’s), 2005 - 2010
    • Table 11: Glucose Monitoring, Revenue ($m), Global, 2002 - 2009
    • Table 12: Glucose Monitoring, Revenue ($m), Global, 2009 - 2016
    • Table 13: Blood Glucose Meters, Revenue ($m), Global, 2002 - 2009
    • Table 14: Blood Glucose Meters, Revenue ($m), Global, 2009 - 2016
    • Table 15: Blood Glucose Test Strips, Revenue ($m), Global, 2002 - 2009
    • Table 16: Blood Glucose Test Strips, Revenue ($m), Global, 2009 - 2016
    • Table 17: Comparison of Insulin Delivery Devices
    • Table 18: Insulin Delivery, Revenue ($m), Global, 2002 - 2009
    • Table 19: Insulin Delivery, Revenue ($m), Global, 2009 - 2016
    • Table 20: Insulin Pumps, Revenue ($m), Global, 2002 - 2009
    • Table 21: Insulin Pumps, Revenue ($m), Global, 2009 - 2016
    • Table 22: Insulin Pens, Revenue ($m), Global, 2002 - 2009
    • Table 23: Insulin Pens, Revenue ($m), Global, 2009 - 2016
    • Table 24: Insulin Syringes, Revenue ($m), Global 2002 - 2009
    • Table 25: Insulin Syringes, Revenue ($m), Global 2009 - 2016
    • Table 26: Diabetes Care Devices Market, Revenue ($m), US, 2002 - 2009
    • Table 27: Diabetes Care Devices Market, Revenue ($m), Canada, 2002 - 2009
    • Table 28: Diabetes Care Devices Market, Revenue ($m), UK, 2002 - 2009
    • Table 29: Diabetes Care Devices Market, Revenue ($m), Germany, 2002 - 2009
    • Table 30: Diabetes Care Devices Market, Revenue ($m), France, 2002 - 2009
    • Table 31: Diabetes Care Devices Market, Revenue ($m), Italy, 2002 - 2009
    • Table 32: Diabetes Care Devices Market, Revenue ($m), Spain, 2002 - 2009
    • Table 33: Diabetes Care Devices Market, Revenue ($m), Japan, 2002 - 2009
    • Table 34: Diabetes Care Devices Market, Revenue ($m), China, 2002 - 2009
    • Table 35: Diabetes Care Devices Market, Revenue ($m), India, 2002 - 2009
    • Table 36: Diabetes Care Devices Market, Revenue ($m), Australia, 2002 - 2009
    • Table 37: Diabetes Care Devices Market, Revenue ($m), Brazil, 2002 - 2009
    • Table 38: Diabetes Care Devices Market, Revenue ($m), US, 2009 - 2016
    • Table 39: Diabetes Care Devices Market, Revenue ($m), Canada, 2009 - 2016
    • Table 40: Diabetes Care Devices Market, Revenue ($m), UK, 2009 - 2016
    • Table 41: Diabetes Care Devices Market, Revenue ($m), Germany, 2009 - 2016
    • Table 42: Diabetes Care Devices Market, Revenue ($m), France, 2009 - 2016
    • Table 43: Diabetes Care Devices Market, Revenue ($m), Italy, 2009 - 2016
    • Table 44: Diabetes Care Devices Market, Revenue ($m), Spain, 2009 - 2016
    • Table 45: Diabetes Care Devices Market, Revenue ($m), Japan, 2009 - 2016
    • Table 46: Diabetes Care Devices Market, Revenue ($m), China, 2009 - 2016
    • Table 47: Diabetes Care Devices Market, Revenue ($m), India, 2009 - 2016
    • Table 48: Diabetes Care Devices Market, Revenue ($m), Australia, 2009 - 2016
    • Table 49: Diabetes Care Devices Market, Revenue ($m), Brazil, 2009 - 2016
    • Table 50: Home Glucose Monitoring Systems Pipeline Product Summary - I
    • Table 51: Home Glucose Monitoring Systems Pipeline Product Summary - II
    • Table 52: Hospital Setting Glucose Monitoring System Pipeline Product Summary
    • Table 53: Home and Hospital Setting Glucose Monitoring Systems Pipeline Product Summary
    • Table 54: Glucose Monitoring Systems Emerging Companies and Products- I
    • Table 55: Glucose Monitoring Systems Emerging Companies and Products - II
    • Table 56: Global Insulin Delivery Devices Pipeline Product Summary
    • Table 57: Closed-loop diabetes management system, Product Status
    • Table 58: Closed-loop diabetes management system, Product Description
    • Table 59: Paradigm Veo System, Product Status
    • Table 60: Paradigm Veo System, Product Description
    • Table 61: Deal Volume By Type, Diabetes Care Devices, 2006-2009
    • Figure 1: Diabetes Care Devices, Revenue ($m), Global, 2002 - 2009
    • Figure 2: Diabetes Care Devices, Revenue ($m), Global, 2009 - 2016
    • Figure 3: Glucose Monitoring Devices, Distribution Channel Share (%), 2008
    • Figure 4: Insulin Delivery, Distribution Channel Share (%), 2008
    • Figure 5: Disposable Insulin Pumps, Revenue ($m), US, 2005 - 2009
    • Figure 6: Disposable Insulin Pumps, Revenue ($m), US, 2009 - 2016
    • Figure 7: Diabetes Care Devices, Global, Company Share (% in Revenue), 2008
    • Figure 8: Glucose Monitoring, Revenue ($m), Global, 2002 - 2009
    • Figure 9: Glucose Monitoring, Revenue ($m), Global, 2009 - 2016
    • Figure 10: Blood Glucose Meters, Revenue ($m), Global, 2002 - 2009
    • Figure 11: Blood Glucose Meters, Revenue ($m), Global, 2009 - 2016
    • Figure 12: Blood Glucose Test Strips, Revenue ($m), Global, 2002 - 2009
    • Figure 13: Blood Glucose Test Strips, Revenue ($m), Global, 2009 - 2016
    • Figure 14: Insulin Delivery, Revenue ($m), Global, 2002 - 2009
    • Figure 15: Insulin Delivery, Revenue ($m), Global, 2009 - 2016
    • Figure 16: Insulin Pumps, Revenue ($m), Global, 2002 - 2009
    • Figure 17: Insulin Pumps, Revenue ($m), Global, 2009 - 2016
    • Figure 18: Insulin Pens, Revenue ($m), Global, 2002 - 2009
    • Figure 19: Insulin Pens, Revenue ($m), Global, 2009 - 2016
    • Figure 20: Insulin Syringes, Revenue ($m), Global 2002 - 2009
    • Figure 21: Insulin Syringes, Revenue ($m), Global 2009 - 2016
    • Figure 22: Key Insulin Delivery Devices: Strategic Product Assessment
    • Figure 23: Insulin Delivery Devices, Company Share (% in Revenues), 2008
    • Figure 24: Glucose Monitoring Systems: Strategic Product Assessment
    • Figure 25: Glucose Monitoring Systems, Company Share (% in Revenues), 2008
    • Figure 26: Diabetes Care Devices Market, Revenue ($m), US, 2002 - 2009
    • Figure 27: Diabetes Care Devices Market, Revenue ($m), Canada, 2002 - 2009
    • Figure 28: Diabetes Care Devices Market, Revenue ($m), UK, 2002 - 2009
    • Figure 29: Diabetes Care Devices Market, Revenue ($m), Germany, 2002 - 2009
    • Figure 30: Diabetes Care Devices Market, Revenue ($m), France, 2002 - 2009
    • Figure 31: Diabetes Care Devices Market, Revenue ($m), Italy, 2002 - 2009
    • Figure 32: Diabetes Care Devices Market, Revenue ($m), Spain, 2002 - 2009
    • Figure 33: Diabetes Care Devices Market, Revenue ($m), Japan, 2002 - 2009
    • Figure 34: Diabetes Care Devices Market, Revenue ($m), China, 2002 - 2009
    • Figure 35: Diabetes Care Devices Market, Revenue ($m), India, 2002 - 2009
    • Figure 36: Diabetes Care Devices Market, Revenue ($m), Australia, 2002 - 2009
    • Figure 37: Diabetes Care Devices Market, Revenue ($m), Brazil, 2002 - 2009
    • Figure 38: Diabetes Care Devices Market, Revenue ($m), US, 2009 - 2016
    • Figure 39: Diabetes Care Devices Market, Revenue ($m), Canada, 2009 - 2016
    • Figure 40: Diabetes Care Devices Market, Revenue ($m), UK, 2009 - 2016
    • Figure 41: Diabetes Care Devices Market, Revenue ($m), Germany, 2009 - 2016
    • Figure 42: Diabetes Care Devices Market, Revenue ($m), France, 2009 - 2016
    • Figure 43: Diabetes Care Devices Market, Revenue ($m), Italy, 2009 - 2016
    • Figure 44: Diabetes Care Devices Market, Revenue ($m), Spain, 2009 - 2016
    • Figure 45: Diabetes Care Devices Market, Revenue ($m), Japan, 2009 - 2016
    • Figure 46: Diabetes Care Devices Market, Revenue ($m), China, 2009 - 2016
    • Figure 47: Diabetes Care Devices Market, Revenue ($m), India, 2009 - 2016
    • Figure 48: Diabetes Care Devices Market, Revenue ($m), Australia, 2009 - 2016
    • Figure 49: Diabetes Care Devices Market, Revenue ($m), Brazil, 2009 - 2016
    • Figure 50: Distribution of Pipeline Products by Stage of Development, Glucose Monitoring
    • Figure 51: Glucose Monitoring Systems Pipeline Product by Product Type
    • Figure 52:The Glucose Monitoring Competitive Landscape to Witness a Price War
    • Figure 53: Distribution of Pipeline Products by Stage of Development, Insulin Delivery
    • Figure 54: Insulin Delivery Devices - Clinical Pipeline by Mode of Insulin Delivery
    • Figure 55: The Insulin Delivery Competitive Landscape to Witness a Race to Capture Unmet Need
    • Figure 56: Deal Volume By Type, Global Diabetes Care Devices, 2006-2009
    • Figure 57: GBI Research Methodology